Benefits in radical mastectomy protocol: a randomized trial evaluating the use of regional anesthesia

Scientific Reports - Tập 8 Số 1
Márcio Matsumoto1, Eva M. Flores1, Pedro Paulo Kimachi1, Flavia Venetucci Gouveia1, Mayra Akemi Kuroki1, Alfredo Carlos Simões Dornellas de Barros1, Marcelo M. C. Sampaio1, Felipe Eduardo Martins de Andrade1, João Valverde1, Eduardo F. Abrantes1, Cláudia Marquez Simões1, Rosana L. Pagano1, Raquel Chacon Ruiz Martinez1
1Hospital Sirio-Libanes, Rua Professor Daher Cutait, 69, 01308-060, Sao Paulo, Brazil

Tóm tắt

AbstractSurgery is the first-line treatment for early, localized, or operable breast cancer. Regional anesthesia during mastectomy may offer the prevention of postoperative pain. One potential protocol is the combination of serratus anterior plane block (SAM block) with pectoral nerve block I (PECS I), but the results and potential benefits are limited. Our study compared general anesthesia with or without SAM block + PECS I during radical mastectomy with axillary node dissection and breast reconstruction using evaluations of pain, opioid consumption, side effects and serum levels of interleukin (IL)-1beta, IL-6 and IL-10. This is a prospective, randomized controlled trial. Fifty patients were randomized to general anesthesia only or general anesthesia associated with SAM block + PECS I (25 per group). The association of SAM block + PECS I with general anesthesia reduced intraoperative fentanyl consumption, morphine use and visual analog pain scale scores in the post-anesthetic care unit (PACU) and at 24 h after surgery. In addition, the anesthetic protocol decreased side effects and sedation 24 h after surgery compared to patients who underwent general anesthesia only. IL-6 levels increased after the surgery compared to baseline levels in both groups, and no differences in IL-10 and IL-1 beta levels were observed. Our protocol improved the outcomes of mastectomy, which highlight the importance of improving mastectomy protocols and focusing on the benefits of regional anesthesia.

Từ khóa


Tài liệu tham khảo

World Health Organization. Global health estimates (WHO, 2013).

PDQ Adult Treatment Editorial Board. Breast cancer treatment (PDQ®): patient version, http://www.ncbi.nlm.nih.gov/books/NBK65969/PubMed (2002).

Smith, H. S. & Wu, S. X. Persistent pain after breast cancer treatment. Ann. Palliat. Med. 1, 182–194 (2012).

Lee, B. M. & Cata, J. P. Impact of anesthesia on cancer recurrence. Rev. Esp. Anestesiol. Reanim. 62, 570–575 (2015).

Deegan, C. A. et al. Anesthetic technique and the cytokine and matrix metalloproteinase response to primary breast cancer surgery. Reg. Anesth. Pain Med. 35, 490–495 (2010).

Hamidullah, C. B. & Konwar, R. Role of interleukin-10 in breast cancer. Breast Cancer Res. Treat. 133, 11–21 (2012).

Carpi, A., Nicolini, A., Antonelli, A., Ferrari, P. & Rossi, G. Cytokines in the management of high risk or advanced breast cancer: an update and expectation. Curr. Cancer Drug Targets 9, 888–903 (2009).

Cheung, Y. T. et al. Association of proinflammatory cytokines and chemotherapy-associated cognitive impairment in breast cancer patients: a multi-centered, prospective, cohort study. Ann. Oncol. 26, 1446–1451 (2015).

Goldberg, J. E. & Schwertfeger, K. L. Proinflammatory cytokines in breast cancer: mechanisms of action and potential targets for therapeutics. Curr. Drug Targets 11, 1133–1146 (2010).

Li, Y. et al. Relationship between IL-10 expression and prognosis in patients with primary breast cancer. Tumor Biol. 35, 11533–11540 (2014).

Lv, M. et al. Cytokines as prognstic tool in breast carcinoma. Front. Biosci. 16, 2515–2526 (2011).

Llanes-Fernández, L. et al. Relationship between IL-10 and tumor markers in breast cancer patients. Breast 15, 482–489 (2006).

Merendino, R. A. et al. Interleukin-12 and interleukin-10 production by mononuclear phagocytic cells from breast cancer patients. Immunol. Lett. 68, 355–358 (1999).

Yang, C. et al. Increased drug resistance in breast cancer by tumor-associated macrophages through IL-10/STAT3/bcl-2 signaling pathway. Med. Oncol. 32, 352 (2015).

Blanco, R. The ‘pecs block’: a novel technique for providing analgesia after breast surgery. Anaesthesia 66, 847–848 (2011).

Blanco, R., Fajardo, M. & Maldonado, T. P. Ultrasound description of Pecs II (modified Pecs I): a novel approach to breast surgery. Rev. Esp. Anestesiol. Reanim. 59, 470–475 (2012).

Bashandy, G. M. N. & Abbas, D. N. Pectoral nerves I and II blocks in multimodal analgesia for breast cancer surgery: a randomized clinical trial. Reg. Anesth. Pain Med. 40, 68–74 (2015).

Blanco, R., Parras, T., McDonnell, J. G. & Prats-Galino, A. Serratus plane block: a novel ultrasound-guided thoracic wall nerve block. Anaesthesia 68, 1107–1113 (2013).

Kamiya, Y., Hasegawa, M., Yoshida, T., Takamatsu, M. & Koyama, Y. Impact of pectoral nerve block on postoperative pain and quality of recovery in patients undergoing breast cancer surgery: a randomised controlled trial. Eur. J. Anaesthesiol. 35, 215–223 (2018).

Bouzinac, A., Brenier, G., Dao, M. & Delbos, A. Bilateral association of pecs I block and serratus plane block for postoperative analgesia after double modified radical mastectomy. Minerva Anestesiol. 81, 589–90 (2015).

Fusco, P., Scimia, P., Marinangeli, F., Pozone, T. & Petrucci, E. The association between the ultrasound-guided Serratus Plane Block and PECS I Block can represent a valid alternative to conventional anesthesia in breast surgery in a seriously ill patient. Minerva Anestesiol. 82, 241–242 (2016).

Guo, Y. et al. Genetically predicted body mass index and breast cancer risk: mendelian randomization analyses of data from 145,000 women of European descent. PLoS Med. 13, e1002105 (2016).

Wang, X. et al. The association between body size and breast cancer in han women in northern and eastern China. Oncologist 21, 1362–1368 (2016).

Mather, L. E., Copeland, S. E. & Ladd, L. A. Acute toxicity of local anesthetics: underlying pharmacokinetic and pharmacodynamic concepts. Reg. Anesth. Pain Med. 30, 553–566 (2005).

Lirk, P., Picardi, S. & Hollmann, M. W. Local anaesthetics. Eur. J. Anaesthesiol. 31, 575–85 (2014).

Greensmith, J. E. & Murray, W. B. Complications of regional anesthesia. Curr. Opin. Anaesthesiol. 19, 531–537 (2006).

Hebl, J. R. & Niesen, A. D. Infectious complications of regional anesthesia. Curr. Opin. Anaesthesiol. 24, 573–580 (2011).

Pace, M. M. et al. Ultrasound-guided thoracic paravertebral blockade: a retrospective study of the incidence of complications. Anesth. Analg. 122, 1186–1191 (2016).

Diéguez, P., Casas, P., López, S. & Fajardo, M. Ultrasound guided nerve block for breast surgery. Rev. Esp. Anestesiol. Reanim. 63, 159–167 (2016).

Kessler, J., Marhofer, P., Hopkins, P. M. & Hollmann, M. W. Peripheral regional anaesthesia and outcome: lessons learned from the last 10 years. Br. J. Anaesth. 114, 728–745 (2015).

Kulhari, S., Bharti, N., Bala, I., Arora, S. & Singh, G. Efficacy of pectoral nerve block versus thoracic paravertebral block for postoperative analgesia after radical mastectomy: a randomized controlled trial. Br. J. Anaesth. 117, 382–386 (2016).

Steyaert, A., Forget, P., Dubois, V., Lavand’homme, P. & De Kock, M. Does the perioperative analgesic/anesthetic regimen influence the prevalence of long-term chronic pain after mastectomy? J. Clin. Anesth. 33, 20–25 (2016).

Smith, I., Monk, T. G., White, P. F. & Ding, Y. Propofol infusion during regional anesthesia: sedative, amnestic, and anxiolytic properties. Anesth. Analg. 79, 313–319 (1994).

Doss, N. W. et al. Continuous thoracic epidural anesthesia with 0.2% ropivacaine versus general anesthesia for perioperative management of modified radical mastectomy. Anesth. Analg. 92, 1552–1557 (2001).

Amin, A. M., Mohammad, M. Y. & Ibrahim, M. F. Comparative study of neuromuscular blocking and hemodynamic effects of rocuronium and cisatracurium under sevoflurane or total intravenous anesthesia. Middle East J. Anaesthesiol. 20, 39–51 (2009).

Chou, R. et al. Management of postoperative pain: a clinical practice guideline from the american pain society, the american society of regional anesthesia and pain medicine, and the american society of anesthesiologists’ committee on regional anesthesia, executive committee, and administrative council. J. Pain 17, 131–157 (2016).

Khemka, R., Chakraborty, A., Ahmed, R., Datta, T. & Agarwal, S. Ultrasound-guided serratus anterior plane block in breast reconstruction surgery. Case Rep. 6, 280–282 (2016).

Kikuchi, M., Takaki, S., Nomura, T. & Goto, T. Difference in the spread of injectate between ultrasound guided pectoral nerve block I and II. a cadaver study. Masui 65, 314–317 (2016).

Rao, V., Dyer, C., Jameel, J., Drew, P. & Greenman, J. Potential prognostic and therapeutic roles for cytokines in breast cancer (Review). Oncol. Rep. 15, 179–185 (2006).

Stewart, T. H. Evidence for immune facilitation of breast cancer growth and for the immune promotion of oncogenesis in breast cancer. Medicina 56, 13–24 (1996).

Mettler, L. et al. Perioperative levels of interleukin-1beta and interleukin-6 in women with breast cancer. Clin. Exp. Obstet. Gynecol. 31, 20–22 (2004).

Fujisaki, K. et al. Cancer-mediated adipose reversion promotes cancer cell migration via IL-6 and MCP-1. Breast Cancer Res. Treat. 150, 255–263 (2015).

Iyengar, N. M. et al. Systemic correlates of white adipose tissue inflammation in early-stage breast cancer. Clin. Cancer Res. 22, 2283–2289 (2015).

Hogevold, H. E., Lyberg, T., Kahler, H., Haug, E. & Reikeras, O. Changes in plasma IL-1beta, TNF-alpha and IL-6 after total hip replacement surgery in general or regional anaesthesia. Cytokine 12, 1156–1159 (2000).

Bravo-Cuellar, A. et al. Comparison of two types of anesthesia on plasma levels of inflammatory markers. Cir. Cir. 75, 99–105 (2007).

Bouhassira, D. et al. Comparison of pain syndromes associated with nervous or somatic lesions and development of a new neuropathic pain diagnostic questionnaire (DN4). Pain 114, 29–36 (2005).

Wu, J. et al. Thoracic paravertebral regional anesthesia improves analgesia after breast cancer surgery: a randomized controlled multicentre clinical trial. Can. J. Anaesth. 62, 241–251 (2014).

Venetsanakos, E., Beckman, I., Bradley, J. & Skinner, J. M. High incidence of interleukin 10 mRNA but not interleukin 2 mRNA detected in human breast tumours. Br. J. Cancer 75, 1826–1830 (1997).

Joimel, U. et al. Stimulation of angiogenesis resulting from cooperation between macrophages and MDA-MB-231 breast cancer cells: proposed molecular mechanism and effect of tetrathiomolybdate. BMC Cancer 10, 375 (2010).

Kaewkangsadan, V. et al. Crucial contributions by T lymphocytes (effector, regulatory, and checkpoint inhibitor) and cytokines (TH1, TH2, and TH17) to a pathological complete response induced by neoadjuvant chemotherapy in women with breast cancer. J. Immunol. Res. 2016, 1–25 (2016).

Kumakura, S. et al. Effects of nitrous oxide on the production of cytokines and chemokines by the airway epithelium during anesthesia with sevoflurane and propofol. Mol. Med. Rep. 8, 1643–1648 (2013).

Couceiro, T. C. D. M., Valença, M. M., Raposo, M. C. F., de Orange, F. A. & Amorim, M. M. R. Prevalence of post-mastectomy pain syndrome and associated risk factors: a cross-sectional cohort study. Pain Manag. Nurs. 15, 731–737 (2014).

Exadaktylos, A. K., Buggy, D. J., Moriarty, D. C., Mascha, E. & Sessler, D. I. Can anesthetic technique for primary breast cancer surgery affect recurrence or metastasis? Anesthesiology 105, 660–664 (2006).

Wijayasinghe, N., Duriaud, H. M., Kehlet, H. & Andersen, K. G. Ultrasound guided intercostobrachial nerve blockade in patients with persistent pain after breast cancer surgery: a pilot study. Pain Physician 19, E309–E318 (2016).

Takimoto, K., Nishijima, K. & Ono, M. Serratus plane block for persistent pain after partial mastectomy and axillary node dissection. Pain Physician 19, E481–E486 (2016).